Endra Life Sciences Inc (NDRA)

[derkampfer]

They will/may need to raise (some) cash. But historically they’ve been very judicious in doing so (small raises), and suspect (based on history) will be done after news which proves tech’s worth and SP significantly higher JUSTIFYING that higher market cap.

I’d rather buy NDRA at $1.0 with the threat of possible 20% dilution than caught in low float bidding war when news released and this screams in AH to god knows where (just as quickly as it dropped post late March preliminary test results). What’s SP when 20% diluted from $3 or $4?

$1.00 is a bargain. Also don’t believe 100% dilution. Not how this company has done raises before.

After listening to CEOs explanation on conference call, preliminary trial results were a lot more clear. And in my opinion very encouraged they know WHAT they need to do and HOW to get there. Again, JMHO.

Good luck to you.